Zhejiang Huahua Gliclazide Sustained-release Tablets Product Leaflet

Gliclazide sustained-release tablets are an oral anti-diabetic drug used to treat adult type 2 diabetes. It can be used alone or in combination with metformin, alpha-glucosidase inhibitors or insulin.


Zhejiang Huahua Gliclazide Sustained-release Tablets Product Leaflet - cover page
Brand
Zhejiang Huahua Pharmaceutical Co., Ltd.
Category
Health Care
Document type
Product Leaflet
Language
Chinese
Pages
2
File format
PDF
File size
218 KB
Published
24 November, 2023
Updated
24 November, 2023
MD5 checksum
7BFC5B3F5B93544B781F49DD4CFDB040

About this manual

This document provides instructions for the use of Gliclazide Sustained-release Tablets, including dosage guidelines for adults with type 2 diabetes. It outlines contraindications, such as type 1 diabetes or severe liver/kidney impairment, and lists potential adverse reactions, including hypoglycemia and gastrointestinal issues. The product is indicated for use when diet, exercise, and weight loss are insufficient to control blood glucose levels.

The leaflet advises patients to take the medication with breakfast and adjust dosage based on blood glucose and HbA1c levels. It also includes warnings about drug interactions and special precautions for patients with renal or hepatic impairment, or those at risk for hypoglycemia. This manual is written in Chinese.

What's inside

  • Drug Name
  • Active Ingredient
  • Indications
  • Dosage and Administration
  • Contraindications
  • Adverse Reactions
  • Precautions
  • Drug Interactions
  • Storage

Specifications

Active IngredientGliclazide
Chemical Name1-(3-Nitrogenous Bicyclo[3.3.0]octyl)-3-p-tolylsulfonamide
Molecular FormulaC15H21N3O3S
Molecular Weight323.4
Dosage FormTablets
Strength30mg

Frequently asked questions

What is the recommended starting dose for Gliclazide Sustained-release Tablets?

The recommended starting dose is 30mg once daily, preferably with breakfast.

Can Gliclazide Sustained-release Tablets be used with other oral antidiabetic drugs?

Yes, it can be used in combination with other oral antidiabetic drugs such as biguanides or alpha-glucosidase inhibitors, but requires careful monitoring.

What are the contraindications for this medication?

It is contraindicated in type 1 diabetes, diabetic coma, severe liver or kidney impairment, and during breastfeeding.

Download PDF (218 KB)